RNA-based therapeutics have emerged as a revolutionary approach for treating genetic disorders, cancers, and infectious diseases. However, delivering RNA molecules safely and efficiently into target cells remains a major challenge. Three leading delivery platforms—exosomes for RNA delivery, liposomes for RNA delivery, and lipid nanoparticles (LNPs) for RNA delivery—have shown significant promise. This article compares these technologies, highlighting their mechanisms, advantages, and limitations.